ABCL - AbCellera Biologics picks internal candidate for CTO

AbCellera Biologics (ABCL) appointed Ester Falconer, Ph.D. as chief technology officer, effective Jan.28.As CTO, Dr. Falconer will lead AbCellera's long-term strategy in the development, aggregation, and integration of technologies that improve the speed and success of therapeutic antibody discovery from target to investigational new drug application submission.Prior to her promotion to CTO, Dr. Falconer was the Head of Research and Development.Also Read: AbCellera shares jump after bamlanivimab combo nabs FDA's EUA for COVID-19 treatment (Feb.10)

For further details see:

AbCellera Biologics picks internal candidate for CTO